Nevakar and Zhaoke Ophthalmology Enter into Licensing Agreement for NVK-002 (Atropine for the Treatment of the Progression of Myopia in Children)
BRIDGEWATER, N.J. & HONG KONG--(BUSINESS WIRE)--Nevakar Inc. (“Nevakar”), a privately held, late-stage, biopharmaceutical company developing multiple innovative medications in the ophthalmic and hospital injectable areas, and Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd. (“ZKO”) announced today that they have recently entered into an exclusive licensing agreement for the development and commercialization of Nevakar’s NVK-002 in Greater China (The People’s Republic of China (“PRC”), Hong